Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

This study is testing whether combining cryoablation (freezing tumors) with two immunotherapy drugs can control both liver cancer and lung metastases in patients with hepatocellular carcinoma (primary liver cancer) that has spread to the lungs and has stopped responding to previous treatments. **You may be eligible if...** - You have primary or recurrent liver cancer (hepatocellular carcinoma) - Your cancer has spread to the lungs with 5 to 10 lung spots, each no larger than 5 cm - Your liver tumors are limited to 5 or fewer, taking up less than half the liver - You have already tried standard first-line treatments (like sorafenib or lenvatinib) and they are no longer working - Your liver tumors are currently stable or responding to prior treatment **You may NOT be eligible if...** - You have cancer spread beyond the lungs - Your liver function is severely compromised - You have serious blood clotting problems in the portal vein Talk to your doctor to see if this trial is right for you.